Anthony Molloy - Jan 18, 2022 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role
Chief Lgl & Compliance Officer
Signature
/s/ Kristen Williams, Attorney-in-Fact
Stock symbol
PCRX
Transactions as of
Jan 18, 2022
Transactions value $
-$14,235
Form type
4
Date filed
1/20/2022, 06:21 PM
Previous filing
Jan 10, 2022
Next filing
Apr 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Sale -$14.2K -224 -1.26% $63.55 17.6K Jan 18, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.